Author:
Logacheva K.,Gergelezhiu P.,Raksha E.,Savostina L.,Arzumanyan G.,Eresko A.,Malakhov S.,Mamatkulov K.,Ponomareva O.,Belushkin A.,Chudoba D.
Reference12 articles.
1. W. J. Phillips and B. L. Currier, “Analgesic pharmacology: II. Specific analgesics,” J. Am. Acad. Orthopaedic Surgeons 12, 221 (2004).
2. T. A. Bailli, W. J. Adams, D. G. Kaiser, L. S. Olanoff, G. W. Halstead, H. Harpootlian, and G. J. Van Giessen, “Mechanistic studies of the metabolic chiral inversion of (R)-Ibuprofen in humans,” J. Pharmacol. Exp. Therapeutics 249, 517 (1989).
3. M. V. Toledo, L. E. Brian, and M. L. Ferreira, “A simple molecular model to study the substrate diffusion into the active site of a lipase-catalyzed esterification of Ibuprofen and Ketoprofen with glycerol,” Top. Catal. 65, 944 (2022).
4. B. Petrie and D. Camacho-Munoz, “Analysis, fate and toxicity of chiral non-steroidal anti-inflammatory drugs in wastewaters and the environment: a review,” Environ. Chem. Lett. 19, 43 (2021).
5. M. O. Amin, E. Al-Hetlani, and I. K. Lednev, “Detection and identification of drug traces in latent fingermarks using Raman spectroscopy,” Sci. Rep. 12, 3136 (2022).